NCT05341050View on ClinicalTrials.gov

A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients With CML

RecruitingOBSERVATIONAL

Enrollment

260

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions

MMR on 12 Month

Interventions

DRUG

TKI

halve dose of 2G-TKI for 12 months and then withdrawal for 12 months

Trial Locations (2)

510515

NOT_YET_RECRUITING

NanfangH, Guangzhou

Unknown

RECRUITING

NanfangH, Guangzhou

All Listed Sponsors

lead

xuna

OTHER